TWST - Twist Bioscience Corp

48.06
1.410   2.934%

Share volume: 1,056,237
Last Updated: 03-04-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances: 0.44%

PREVIOUS CLOSE
CHG
CHG%
$46.65
1.41
0.03%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
8%
Profitability 0%
Dept financing 7%
Liquidity 75%
Performance 0%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
4.73%
1 Month
2.04%
3 Months
48.79%
6 Months
86.57%
1 Year
14.29%
2 Year
30.63%
Key data
Stock price
$48.06
P/E Ratio 
0.00
DAY RANGE
$46.82 - $49.32
EPS 
-$1.27
52 WEEK RANGE
$23.30 - $57.88
52 WEEK CHANGE
$22.66
MARKET CAP 
1.940 B
YIELD 
N/A
SHARES OUTSTANDING 
61.312 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
08-01-2025
BETA 
3.13
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$893,512
AVERAGE 30 VOLUME 
$1,462,532
Company detail
CEO: Emily M. Leproust
Region: US
Website: twistbioscience.com
Employees: 990
IPO year: 2018
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Sector: Manufacturing

Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital data storage medium.

Recent news